N

Nykode Therapeutics ASA
OSE:NYKD

Watchlist Manager
Nykode Therapeutics ASA
OSE:NYKD
Watchlist
Price: 1.72 NOK -0.12% Market Closed
Market Cap: 561.7m NOK

Wall Street
Price Targets

NYKD Price Targets Summary
Nykode Therapeutics ASA

Wall Street analysts forecast NYKD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NYKD is 5.2 NOK with a low forecast of 1.82 NOK and a high forecast of 8.93 NOK.

Lowest
Price Target
1.82 NOK
6% Upside
Average
Price Target
5.2 NOK
202% Upside
Highest
Price Target
8.93 NOK
419% Upside
Nykode Therapeutics ASA Competitors:
Price Targets
ALKS
Alkermes Plc
29% Upside
DSGN
Design Therapeutics Inc
87% Upside
BSLN
Basilea Pharmaceutica AG
78% Upside
MNKD
MannKind Corp
140% Upside
HUMA
Humacyte Inc
271% Upside
CYTK
Cytokinetics Inc
134% Upside
ANAB
AnaptysBio Inc
76% Upside
NTRA
Natera Inc
25% Upside

Revenue
Forecast

Revenue Estimate
Nykode Therapeutics ASA

For the last 7 years the compound annual growth rate for Nykode Therapeutics ASA's revenue is 110%.

110%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Nykode Therapeutics ASA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Nykode Therapeutics ASA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NYKD's stock price target?
Price Target
5.2 NOK

According to Wall Street analysts, the average 1-year price target for NYKD is 5.2 NOK with a low forecast of 1.82 NOK and a high forecast of 8.93 NOK.

Back to Top